Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-08 |
2024-03 |
-0.72 |
-0.88 |
-0.16 |
-22.22% |
2024-03-28 |
2023-12 |
-0.62 |
-0.89 |
-0.27 |
-43.55% |
2023-11-09 |
2023-09 |
-0.94 |
-0.92 |
0.02 |
2.13% |
2023-08-10 |
2023-06 |
-1.5 |
-2.36 |
-0.86 |
-57.33% |
2023-05-11 |
2023-03 |
-1.7 |
-1.7 |
N/A |
N/A |
2023-03-29 |
2022-12 |
-1.6 |
-1.4 |
0.2 |
12.50% |
Date |
Name |
Relation |
Quantity |
Description |
2023-05-18 |
BROWN THOMAS D |
Director |
116.16K |
Conversion of Exercise of derivative security |
2023-05-30 |
BURRIS WAYNE C. |
Director |
8.39K |
Conversion of Exercise of derivative security |
2024-01-22 |
FRANCESCONI LOUISE L |
Director |
20.93K |
Purchase |
2024-01-22 |
MASSARANY HANY |
Director |
27.26K |
Purchase |
2023-05-21 |
MERTZ LARRY MICHAEL |
Chief Technology Officer |
525.70K |
Sale |
2024-02-25 |
PATIENCE DAVID |
Chief Financial Officer |
27.01K |
Sale |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-09-29 |
Griffin Asset Management, Inc. |
1.18M |
6.81M |
8.24% |
2023-06-29 |
Vanguard Group Inc |
289.84K |
234.77K |
2.02% |
2023-06-29 |
Birchview Capital, LP |
225.24K |
182.44K |
1.57% |
2023-06-29 |
Oracle Investment Management Inc |
151.07K |
122.36K |
1.05% |
2023-06-29 |
Tudor Investment Corporation |
141.14K |
114.33K |
0.98% |
2023-06-29 |
Alyeska Investment Group, L.p. |
123.90K |
100.36K |
0.86% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
223.46K |
181.00K |
1.56% |
2023-06-29 |
Vanguard Extended Market Index Fund |
57.22K |
46.35K |
0.40% |
2023-05-30 |
Fidelity Extended Market Index Fund |
21.42K |
15.01K |
0.15% |
2023-09-29 |
Thompson Mid Cap Fund |
11.39K |
65.49K |
0.08% |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
8.35K |
5.85K |
0.06% |
2023-05-30 |
Fidelity Total Market Index Fund |
8.86K |
6.21K |
0.06% |
Split |
Date |
1 : 10 |
2023-07-12 |